CN103751469A - Composition for treating qi and blood stasis type systemic scleroderma - Google Patents
Composition for treating qi and blood stasis type systemic scleroderma Download PDFInfo
- Publication number
- CN103751469A CN103751469A CN201410004913.0A CN201410004913A CN103751469A CN 103751469 A CN103751469 A CN 103751469A CN 201410004913 A CN201410004913 A CN 201410004913A CN 103751469 A CN103751469 A CN 103751469A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- composition
- systemic scleroderma
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a composition for treating qi and blood stasis type systemic scleroderma, relating to the field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 10-15 parts of scorpio, 8-12 parts of peach seed, 8-12 parts of safflower, 10-15 parts of angelica sinensis, 6-12 parts of ligusticum wallichii, 10-15 parts of radix paeoniae alba, 8-12 parts of radix rehmanniae, 12-18 parts of rhizoma cyperi, 10-15 parts of fructus aurantii, 8-12 parts of szechwan Chinaberry fruit, 10-15 parts of radix bupleuri, 8-12 parts of rhizoma corydalis, 5-8 parts of trogopterus dung and 5-8 parts of liquorice root. The composition for treating qi and blood stasis type systemic scleroderma, provided by the invention is reasonable in compatibility, has the functions of promoting circulation, removing stasis, dredging collaterals and resolving hard lump, and has a good treatment effect on the systemic scleroderma; the effective rate of the composition can reach above 85 percent, and the cure rate of the systemic scleroderma can reach above 75 percent.
Description
Technical field:
The present invention relates to tcm field, relate in particular to a kind of compositions for the treatment of stagnation of QI-blood type systemic sclerosis.
Background technology:
Scleroderma is a kind ofly with skin fiber, to turn to master, and involves the autoimmune disease of blood vessel and internal organs.Primary disease weight degree of variation is very large, and wherein a part of patient's pathological changes is the optimum skin lesion of limitation, is called local scleroderma, and another part patient has skin lesion widely, and involves internal organs, is called systemic sclerosis.The most of patients state of an illness develops gradually, and visceral lesion increases the weight of gradually, and age of onset is many between 20-50 year, and the 3-8 that women's sickness rate is about male doubly.The at present treatment for this disease lacks eutherapeutic medicine, and the medicine using at present has: blood vessel dilating medicine, adrenocortical hormone, anti-fibrosis medicine, improve microcirculation medicine, immunosuppressant.But curative effect is all undesirable.
Summary of the invention:
The object of the present invention is to provide a kind of compositions for the treatment of stagnation of QI-blood type systemic sclerosis, to solve the problems of the technologies described above.
Technical problem to be solved by this invention realizes by the following technical solutions:
A compositions for the treatment of stagnation of QI-blood type systemic sclerosis, is characterized in that, comprises following component and group component:
Scorpio 10-15 part Semen Persicae 8-12 part
Flos Carthami 8-12 part Radix Angelicae Sinensis 10-15 part
Rhizoma Chuanxiong 6-12 part Radix Paeoniae Alba 10-15 part
Radix Rehmanniae 8-12 part Rhizoma Cyperi 12-18 part
Fructus Aurantii 10-15 part Fructus Toosendan 8-12 part
Radix Bupleuri 10-15 part Rhizoma Corydalis 8-12 part
Oletum Trogopterori 5-8 part Radix Glycyrrhizae 5-8 part.
The preferred group component of each component is:
10 parts, 12 parts of Semen Persicaes of Scorpio
12 parts of 10 parts of Radix Angelicae Sinensis of Flos Carthami
12 parts of 9 portions of Radix Paeoniae Albas of Rhizoma Chuanxiong
15 parts of 10 portions of Rhizoma Cyperis of the Radix Rehmanniae
10 parts of 12 parts of Fructus Toosendans of Fructus Aurantii
10 parts of 12 parts of Rhizoma Corydalis of Radix Bupleuri
6 parts, 6 portions of Radix Glycyrrhizaes of Oletum Trogopterori.
This pharmaceutical composition adopts traditional approach decoction, every day potion, decoction liquor is divided and is taken for 2-3 time.
The invention has the beneficial effects as follows:
The compositions for the treatment of stagnation of QI-blood type systemic sclerosis provided by the invention, compatibility is reasonable, has the effect of blood circulation promoting and blood stasis dispelling, dredging collateral, hard masses softening and resolving, good to sclerodermatous therapeutic effect, and effective percentage can reach more than 85%, and cure rate can reach more than 75%.
The specific embodiment:
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
Treat a compositions for stagnation of QI-blood type systemic sclerosis, component is:
8 parts, 10 parts of Semen Persicaes of Scorpio
10 parts of 8 parts of Radix Angelicae Sinensis of Flos Carthami
10 parts of 6 portions of Radix Paeoniae Albas of Rhizoma Chuanxiong
12 parts of 8 portions of Rhizoma Cyperis of the Radix Rehmanniae
8 parts of 10 parts of Fructus Toosendans of Fructus Aurantii
8 parts of 10 parts of Rhizoma Corydalis of Radix Bupleuri
5 parts, 5 portions of Radix Glycyrrhizaes of Oletum Trogopterori
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 2
Treat a compositions for stagnation of QI-blood type systemic sclerosis, component is:
12 parts, 15 parts of Semen Persicaes of Scorpio
15 parts of 12 parts of Radix Angelicae Sinensis of Flos Carthami
15 parts of 12 portions of Radix Paeoniae Albas of Rhizoma Chuanxiong
18 parts of 12 portions of Rhizoma Cyperis of the Radix Rehmanniae
12 parts of 15 parts of Fructus Toosendans of Fructus Aurantii
12 parts of 15 parts of Rhizoma Corydalis of Radix Bupleuri
8 parts, 8 portions of Radix Glycyrrhizaes of Oletum Trogopterori
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 3
Treat a compositions for stagnation of QI-blood type systemic sclerosis, component is:
10 parts, 12 parts of Semen Persicaes of Scorpio
12 parts of 10 parts of Radix Angelicae Sinensis of Flos Carthami
12 parts of 9 portions of Radix Paeoniae Albas of Rhizoma Chuanxiong
15 parts of 10 portions of Rhizoma Cyperis of the Radix Rehmanniae
10 parts of 12 parts of Fructus Toosendans of Fructus Aurantii
10 parts of 12 parts of Rhizoma Corydalis of Radix Bupleuri
6 parts, 6 portions of Radix Glycyrrhizaes of Oletum Trogopterori
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Classical case
What so-and-so, female, 28 years old, people from Wuwei County, Anhui Province, suffered from scleroderma, and once all invalid many hospitalizes, the state of an illness further develops, and can not stablize.Symptom: face and whole body pigementation, body is thin, and skin is hard, pressure hard as tire.With arthralgia, cannot squat down, tongue body is slightly stiff, and matter is red, and tongue is white, hypomenorrhea, hectic fever in the afternoon, defecation is normal, deep-thready pulse.Take compositions of the present invention and treat, take after ten doses, through further consultation, hectic fever in the afternoon goes down, and spirit is clearly better, and arthralgia slightly subtracts.Continue to take compositions of the present invention and treat, serve on after 30 doses, diagnosis again, above-mentioned symptom all improves by a relatively large margin, then adheres to medication treatment one month, is almost recovered.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what in above-described embodiment and description, describe is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.
Claims (2)
1. a compositions for the treatment of stagnation of QI-blood type systemic sclerosis, is characterized in that, comprises following component and group component:
Scorpio 10-15 part Semen Persicae 8-12 part
Flos Carthami 8-12 part Radix Angelicae Sinensis 10-15 part
Rhizoma Chuanxiong 6-12 part Radix Paeoniae Alba 10-15 part
Radix Rehmanniae 8-12 part Rhizoma Cyperi 12-18 part
Fructus Aurantii 10-15 part Fructus Toosendan 8-12 part
Radix Bupleuri 10-15 part Rhizoma Corydalis 8-12 part
Oletum Trogopterori 5-8 part Radix Glycyrrhizae 5-8 part.
2. the compositions for the treatment of stagnation of QI-blood type systemic sclerosis according to claim 1, is characterized in that, the preferred group component of each component is:
10 parts, 12 parts of Semen Persicaes of Scorpio
12 parts of 10 parts of Radix Angelicae Sinensis of Flos Carthami
12 parts of 9 portions of Radix Paeoniae Albas of Rhizoma Chuanxiong
15 parts of 10 portions of Rhizoma Cyperis of the Radix Rehmanniae
10 parts of 12 parts of Fructus Toosendans of Fructus Aurantii
10 parts of 12 parts of Rhizoma Corydalis of Radix Bupleuri
6 parts, 6 portions of Radix Glycyrrhizaes of Oletum Trogopterori.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410004913.0A CN103751469A (en) | 2014-01-03 | 2014-01-03 | Composition for treating qi and blood stasis type systemic scleroderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410004913.0A CN103751469A (en) | 2014-01-03 | 2014-01-03 | Composition for treating qi and blood stasis type systemic scleroderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103751469A true CN103751469A (en) | 2014-04-30 |
Family
ID=50518896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410004913.0A Pending CN103751469A (en) | 2014-01-03 | 2014-01-03 | Composition for treating qi and blood stasis type systemic scleroderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103751469A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524128A (en) * | 2015-01-09 | 2015-04-22 | 杨茹芹 | Traditional Chinese medicine composition treating cold blood stasis type scleroderma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048900A (en) * | 2009-11-09 | 2011-05-11 | 景松森 | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion |
| CN102078470A (en) * | 2009-12-01 | 2011-06-01 | 邓晓莉 | Traditional Chinese medicine composition for treating vital energy stagnation blood stasis type dysmenorrhea |
| CN102210847A (en) * | 2011-05-21 | 2011-10-12 | 韩瑜 | Method for preparing medicinal composition capsules for treating dysmenorrheal and application thereof |
-
2014
- 2014-01-03 CN CN201410004913.0A patent/CN103751469A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048900A (en) * | 2009-11-09 | 2011-05-11 | 景松森 | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion |
| CN102078470A (en) * | 2009-12-01 | 2011-06-01 | 邓晓莉 | Traditional Chinese medicine composition for treating vital energy stagnation blood stasis type dysmenorrhea |
| CN102210847A (en) * | 2011-05-21 | 2011-10-12 | 韩瑜 | Method for preparing medicinal composition capsules for treating dysmenorrheal and application thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524128A (en) * | 2015-01-09 | 2015-04-22 | 杨茹芹 | Traditional Chinese medicine composition treating cold blood stasis type scleroderma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173704A (en) | Traditional Chinese medicine decoction for treating subacute thyroiditis | |
| CN103393966B (en) | A kind of Chinese medicine composition for the treatment of menoxenia | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN101129496A (en) | Traditional Chinese medicine for treating intractable headache | |
| CN103721024A (en) | Traditional Chinese medicine composition for treating chronic rhinitis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN101130054A (en) | Traditional Chinese medicine for treating phlegm-turbidity internal-resistance type dizziness | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN104306662A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method thereof | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN104069386A (en) | Traditional Chinese medicine for treating chronic cervicitis | |
| CN103751469A (en) | Composition for treating qi and blood stasis type systemic scleroderma | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103751639A (en) | Composition for treating virulent heat-evil type circumscribed scleroderma | |
| CN103301429B (en) | Oral preparation for treating women dysmenorrhea | |
| CN103816343A (en) | Traditional Chinese medicine composition for treating head ring of old people | |
| CN103816398A (en) | Medicine composition for treating stroke and cerebral thrombosis | |
| CN103751402A (en) | Composition for treating qi stagnation and blood stasis type localized scleroderma | |
| CN107753700A (en) | A kind of medicine for treating chronic hepatitis | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN103735718A (en) | Composition for treating cold-damp collateral obstruction type systemic scleroderma | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN101502597A (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105816613A (en) | Traditional Chinese medicine composition for treating headache caused by liver-yang hyperactivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140430 |